Recombinant Anti-ERLEC1 antibody [EPR13849] 100ul and 1 more item
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0238161-V3
- Awardee
- Epitomics Inc
- Contracting organization
- University of Virginia
- Cumulative value
- $420.00
About this award
On August 8, 2026, the University of Virginia awarded contract A207_PO-0238161-V3 to Epitomics Inc, a prime contractor based in Virginia. The cumulative contract value totals $420. The primary deliverable consists of 420 vials of Recombinant Anti-ERLEC1 antibody [EPR13849] at 100 microliters per unit, with a unit price of $1 per vial. The contract also includes shipping and handling services, priced at $1 per transaction.
The contract specifies delivery to the buyer with performance under the jurisdiction of Virginia. No specific county, place of performance location, or contract period of performance dates beyond the award date are identified in the provided documentation. The line item quantities and unit pricing indicate a straightforward procurement of research-grade biological reagents and associated logistics support for the University of Virginia's operational requirements.
Line items
| Item | Total |
|---|---|
| Recombinant Anti-ERLEC1 antibody [EPR13849] 100ul | $420.00 |
| shipping and handling | — |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0238161-V3?
Contract A207_PO-0238161-V3 was awarded to Epitomics Inc by University of Virginia on August 8, 2026.
How much is contract A207_PO-0238161-V3 worth?
Its cumulative value is $420.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award